FindTrial
Sign In

To Evaluate the effect of mustadi yapana basti on the process of spermatogenesis

Use of Biomarkers to Evaluate Physiological Effect of YapanaBasti on Shukra Dhatu

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020538
Enrollment
40
Registered
2019-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

Intervention1: MUSTADI YAPANA BASTI: IT IS PANCHKARMA INTERVATION ,GIVEN DAILY FOR 15 DAYS PER RECTUM Control Intervention1: MUSTADI YAPANA BASTTI: IT IS PANCHKARMA INTERVENTION GIVEN PER RECTUM DAILY

Sponsors

AYURVEDIC AND UNANI TIBBIA COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 2. No history of serious illness or disease 3. Not under any type of medical treatment since last six months. 4. Subjects having sperm count 05 to 15 million per ml (Group A) 5. Subjects having sperm count More than 15 million per ml (Group B). 6. Subjects who are able to come for follow up on fixed visits and are well aware about the treatment plans. 7. Subjects willing to participate and able to give written informed consent

Exclusion criteria

Exclusion criteria: 1. Subject having Age below 20 years and more than 40 year 2. Patients suffering from congenital anomalies 3. Subject of Type-I DM or Type-II DM on insulin 4. Hereditary Disease 5. The patients having Varicocele, Testicular maldescent, previous reproductive surgery, STD were excluded 6. Patient of Azoospermia and Aspermia. 7. Taking treatment for major psychiatric problem. 8. Illness necessitating long term drug treatment (Rheumatoid arthritis ,Diabetes Mellitus ,Psychoneuro endocrinal disorder ,TB,AIDS) 9. Uncontrolled Hypertensive patients (BP with or without medication greater than 140/90mm Hg after 5 min of rest) 10. Subjects with any unstable heart disease or known case of MI ,Unstable angina. 11. Subjects who have a recent history or who are currently known to abuse of alcohol or drugs. 12. Subjects on systemic or oral steroids. 13. H/o hypersensitivity to any of the Herbs to be use in intervention. 14. Subjects who have completed participation in any other clinical trial during the past six month.

Design outcomes

Primary

MeasureTime frame
EFFECT ON SPERM COUNT AND BIOMARKERS OF SPERMATOGENESISTimepoint: ONE MONTH—

Secondary

MeasureTime frame
IMPROVEMENT ON INTERNATIONAL ERECTILE DYSFUNCTION SCORE AND LAKSHAN OF SHUKRA KSHYATimepoint: ONE MONTH—

Countries

India

Contacts

Public ContactDR ANKUR KUMAR TANWAR

AYURVEDIC AND UNANI TIBBIA COLLEGE AND HOSPITAL

sujataa.rajan@gmail.com9818473595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026